Tempus Achieves Record Total Contract Value Exceeding $1.1 Billion

Core Insights - Tempus AI, Inc. has achieved a record Total Contract Value (TCV) exceeding $1.1 billion as of December 31, 2025 [1] - The company signed data agreements with over 70 customers in 2025, including major pharmaceutical companies [1] Company Overview - Tempus AI, Inc. is a technology company focused on advancing precision medicine through the adoption of artificial intelligence [1] - The company operates in the healthcare technology sector, specifically targeting the pharmaceutical industry [1] Customer Engagement - The customer base includes both large and mid-sized pharmaceutical companies such as AstraZeneca, GlaxoSmithKline, Bristol Myers Squibb, Pfizer, Novartis, Merck, Abbvie, Daiichi Sankyo, Eli Lilly, and Boehringer Ingelheim [1] - The agreements signed in 2025 reflect a strong demand for Tempus's AI-driven solutions in the pharmaceutical sector [1]